Skip to main content
. 2022 Jun 28;13:917304. doi: 10.3389/fendo.2022.917304

Figure 3.

Figure 3

Nomogram estimating the likelihood of fibrosis progression in T2DM patients with NAFLD. T2DM, type 2 diabetes mellitus; NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; HbA1c, glycosylated hemoglobin A1c; ALT, alanine aminotransferase ratio; PLT, platelet counts.